Synthego Gets $41M For Genome Engineering
Redwood City-based Synthego, which develops a synthetic RNA designed for genome engineering, has raised $41M in a Series B funding round. The funding was led by 8VC, and also included AME Cloud Ventures, Elements Capital, OS Fund, Alexandria Equities, ZhenFund, Founders Fund, Menlo Ventures, WI Harper Group, and Max Levchin's SciFi VC, along with other angels. The company said the funding goes towards commercial operations, international expansion, and introduction of new products.
posted on Wednesday, January 4, 2017
Related companies:
Synthego Corp
Related stories:
> Twist Bioscience Buys Genome Compiler
> Intel Capital Invests $60M In 15 Startups
> Genome Medical Gains $23M
> Polybit Finds $2M For StdLib
> Personalis Raises $22M For Genome Sequencing
silicontap.com Home